Rafar SRL
The score of Rafar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rafar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 24 Sep 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Rafar's financial analysis
- Solvency89.4%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rafar
Rafar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0866.855.049
- VAT number
- BE0866855049
- Peppol
- Registered · 0208:0866855049 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Aug 2004
- Registered office
- 6460 Chimay
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Rafar (SRL) has been based in Chimay since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 47,395 € and equity of €1.25m; its revenue is not published. Its solvency stands at 89.4%, above the median of its sector (40.1%).
Companies similar to Rafar
Companies in the same business, of comparable size and area, outside its group.
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek DE Vuurtoren Retail sale of pharmaceutical products Ostend · balance sheet €1.40m
- WLM Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet €1.38m
- Dieusaert Pharma Retail sale of pharmaceutical products Heuvelland · balance sheet €1.41m
- EVDW Retail sale of pharmaceutical products Ghent · balance sheet €1.38m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
Frequently asked questions about Rafar
What is the revenue of Rafar?
Rafar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rafar?
In Belgium, the VAT number is the company number prefixed with BE: BE0866855049 for Rafar, if the company is VAT-registered. Its company number (CBE) is 0866.855.049.
Where is the registered office of Rafar?
According to the CBE register, the registered office of Rafar is in 6460 Chimay.
What is the equity of Rafar?
At the close of the 2025 financial year, the equity of Rafar amounts to 1,247,150 €, a solvency of 89.4% of total assets.
Who manages Rafar?
The register lists 1 active mandates at Rafar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rafar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →